Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

You are here: Home » CRO/CMO Services

CRO/CMO Services


The following articles are focused on China Contract Research Organizations (CROs) and Contract Manfacturing Organizations (CMOs) offering both clinical and pre-clinical services.  Included are news, deals and company information.

Recent Articles

  ShangPharma Forms Drug Translation Collaboration with UCSF
  WuXi Biologics Rises 37% in First Hong Kong Trading Session
  WuXi Biologics Prices Hong Kong IPO at $511 Million
  WuXi NextCODE in Hunt for $200 Million in Venture Capital
  Boehringer Ingelheim Opens $77 Million Shanghai Biologics CMO Plant; Establishes R&D Partnership with Peking University
  WuXi NextCODE Raises $75 Million for Genomics Operations
  Beijing's Novogen Orders 25 of Illumina's Latest Sequencing Machines
  WuXi AppTec Plans China IPO
  WuXi AppTec's STA Pharma to Expand Changzhou Site
  WuXi AppTec Acquires HD Biosciences, a Biologics CRO